# Night waking during perimenopause

Reviewed 2026-11-10

Source edition: [My Wife Keeps Waking at 3:30. I Went Looking for Why.](https://www.andreheeg.com/archive/my-wife-keeps-waking-at-330-i-went-looking-for-why) (2026-10-25).

What sleep recordings, hormone therapy trials and telephone CBT-I tell us about broken sleep in midlife.

## Key takeaways

- In a study of 168 midlife women, the odds of waking during a measured hot flash were about five times the odds just before it. That comparison cannot identify the cause of an individual awakening. [[5]](<https://doi.org/10.1093/sleep/zsz131>)
- Telephone cognitive behavioral therapy for insomnia (CBT-I) improved sleep in a trial of women with both insomnia and hot flashes. [[14]](<https://doi.org/10.1001/jamainternmed.2016.1795>)

## Questions

### How common are insomnia symptoms during the transition?

A 2026 review estimated that about 27% of perimenopausal women and 42% of postmenopausal women reported symptoms. These are pooled estimates across groups that used different measures. [[3]](<https://doi.org/10.1016/j.genhosppsych.2026.03.010>)

### Does hormone therapy help women sleep through the night?

Sleep improved most clearly in trials that enrolled women with hot flashes or night sweats. The benefit for women without these symptoms was uncertain. [[12]](<https://doi.org/10.1007/s12020-016-1072-9>)

### What did the progesterone trials actually measure?

Most participants were postmenopausal. Pooled data favored micronized progesterone for falling asleep. The estimates for total sleep time and sleep efficiency were inconclusive. [[7]](<https://doi.org/10.1210/clinem/dgaa873>)

### Does switching from a contraceptive pill to micronized progesterone preserve contraception?

Micronized progesterone used in menopausal hormone therapy does not prevent pregnancy. Anyone who still needs contraception should discuss a separate method with their prescriber. [[17]](<https://www.nhs.uk/medicines/hormone-replacement-therapy-hrt/utrogestan-micronised-progesterone/common-questions-about-utrogestan/>)

### What does CBT-I involve?

CBT-I addresses habits and expectations that keep insomnia going. The McCurry trial delivered it over the phone. The American Academy of Sleep Medicine recommends multicomponent CBT-I for adults with chronic insomnia. [[13]](<https://doi.org/10.5664/jcsm.8986>) [[14]](<https://doi.org/10.1001/jamainternmed.2016.1795>)

### Why might someone with insomnia be assessed for sleep apnea?

Women can describe disrupted sleep or fatigue as their main complaint. Reproductive aging is associated with a higher risk of obstructive sleep apnea. A clinical assessment can distinguish causes that need different treatment. [[16]](<https://doi.org/10.1016/j.chest.2025.08.001>)

## References

1. [Merck Manual Consumer Version. (2026). Menopause.](<https://www.merckmanuals.com/home/women-s-health-issues/menopause/menopause>)
2. [McEvoy, K., & Osborne, L. M. (2019). Allopregnanolone and reproductive psychiatry: An overview. International Review of Psychiatry, 31(3), 237–244.](<https://doi.org/10.1080/09540261.2018.1553775>)
3. [Balasubramanian, I., Abhijita, B., Krishnamoorthy, Y., Gnanadhas, J., Beg, M. J., & Menon, V. (2026). Prevalence and incidence of depressive, anxiety, and insomnia symptoms in perimenopausal and postmenopausal women: Systematic review and meta-analysis. General Hospital Psychiatry, 100, 325–335.](<https://doi.org/10.1016/j.genhosppsych.2026.03.010>)
4. [Prague, J. K., et al. (2017). Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo-controlled trial. The Lancet, 389(10081), 1809–1820.](<https://doi.org/10.1016/S0140-6736(17)30823-1>)
5. [Thurston, R. C., Chang, Y., Buysse, D. J., Hall, M. H., & Matthews, K. A. (2019). Hot flashes and awakenings among midlife women. Sleep, 42(9), zsz131.](<https://doi.org/10.1093/sleep/zsz131>)
6. [Fachinfo-Service. (n.d.). Jubrele 75 Mikrogramm Filmtabletten: Fachinformation (Desogestrel).](<https://www.fachinfo.de/fi/detail/013955/jubrele>)
7. [Nolan, B. J., Liang, B., & Cheung, A. S. (2021). Efficacy of micronized progesterone for sleep: A systematic review and meta-analysis of randomized controlled trial data. The Journal of Clinical Endocrinology & Metabolism, 106(4), 942–951.](<https://doi.org/10.1210/clinem/dgaa873>)
8. [British Menopause Society. (n.d.). Progestogens and endometrial protection [BMS Tools for Clinicians].](<https://thebms.org.uk/wp-content/uploads/2023/04/14-BMS-TfC-Progestogens-and-endometrial-protection-APR2023-A.pdf>)
9. [Rossouw, J. E., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321–333.](<https://doi.org/10.1001/jama.288.3.321>)
10. [U.S. Food and Drug Administration. (2026). FDA approves labeling changes to menopausal hormone therapy products](<https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products>)
11. [The North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794.](<https://doi.org/10.1097/GME.0000000000002028>)
12. [Cintron, D., et al. (2017). Efficacy of menopausal hormone therapy on sleep quality: Systematic review and meta-analysis. Endocrine, 55(3), 702–711.](<https://doi.org/10.1007/s12020-016-1072-9>)
13. [Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262.](<https://doi.org/10.5664/jcsm.8986>)
14. [McCurry, S. M., et al. (2016). Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: A MsFLASH randomized clinical trial. JAMA Internal Medicine, 176(7), 913–920.](<https://doi.org/10.1001/jamainternmed.2016.1795>)
15. [somnio. (2025). So verordnen Sie somnio Ihren Patient:innen.](<https://somn.io/fachkreise/somnio-verschreiben/>)
16. [Dunietz, G. L., Chervin, R. D., Tauman, R., Shaklai, S., & Sankari, A. (2026). OSA in women: Associations with reproductive aging and screening challenges. Chest, 169(3), 803–812.](<https://doi.org/10.1016/j.chest.2025.08.001>)
17. [NHS (n.d.). Common questions about Utrogestan.](<https://www.nhs.uk/medicines/hormone-replacement-therapy-hrt/utrogestan-micronised-progesterone/common-questions-about-utrogestan/>)

This pack covers the companion statements above. It is educational and does not provide individual medical advice or certify every claim in the original newsletter.
